Gabapentin can affect memory. The drug’s most commonly reported cognitive side effects include drowsiness, confusion, and difficulty thinking clearly, and these effects appear to be dose-dependent. A large population study also found that gabapentin use was associated with a higher risk of developing dementia over time, raising questions about its long-term impact on brain health.
How Gabapentin Changes Brain Chemistry
Gabapentin works by binding to a specific protein on nerve cells called alpha-2-delta-1, which plays a key role in forming new connections between brain cells. When gabapentin attaches to this protein, it blocks the signaling that normally drives new excitatory synapse formation. In simpler terms, the drug dials down the brain’s ability to build and strengthen the wiring between neurons, which is one reason it’s effective for seizures and nerve pain but also why it can interfere with cognitive processes like learning and memory.
The drug also raises levels of GABA, the brain’s main calming chemical, by an average of about 56% after a single dose. GABA slows neural activity, which is why gabapentin often causes sedation and mental fogginess. At the same time, gabapentin reduces calcium flow into nerve terminals that release glutamate, the brain’s primary excitatory chemical. The net result is a quieter, slower brain. That’s therapeutic for someone with overactive nerve signals causing pain or seizures, but it can also make thinking feel sluggish and make it harder to encode new memories.
Dose Matters More Than Most People Realize
The cognitive side effects of gabapentin are clearly tied to how much you take. A large Canadian study of over 110,000 older adults (average age 76) found that people starting on doses above 600 mg per day had a 29% higher risk of being hospitalized for altered mental status compared to those on 600 mg per day or less. Altered mental status in this context included confusion, disorientation, and significant cognitive impairment.
For context, the typical prescribed dose for nerve pain starts at 900 mg per day and can go as high as 1,800 mg. For epilepsy, doses sometimes reach 2,400 mg per day. Pain relief has been demonstrated at doses as low as 900 mg daily in about 43% of patients, which means some people may be taking more than they need. If you’re experiencing brain fog or memory trouble on gabapentin, the dose you’re on is the first thing worth discussing with your prescriber.
The Dementia Question
A large Taiwanese study using national health insurance records found that people who used gabapentin or pregabalin (a closely related drug) had a statistically higher risk of developing dementia compared to non-users. The association was strongest in younger users: people under 50 had roughly three times the risk, while those 70 and older had about 1.3 times the risk. The age groups in between fell on a gradient, with 50- to 59-year-olds at about 1.6 times the risk and 60- to 69-year-olds at about 1.5 times.
These numbers deserve careful interpretation. This was an observational study, meaning it tracked patterns in a population but couldn’t prove gabapentin directly caused dementia. People taking gabapentin often have chronic pain, epilepsy, or other conditions that themselves carry cognitive risks. The higher relative risk in younger people may partly reflect the fact that dementia is so rare under 50 that even a small number of cases creates a large percentage increase. Still, the findings are concerning enough that researchers and clinicians have flagged them as a signal worth taking seriously, particularly for people on the drug long-term.
Older Adults Face Higher Risks
Gabapentin is listed in the American Geriatrics Society Beers Criteria, a widely used guide to medications that are potentially inappropriate for older adults. It earned that designation because of its association with severe sedation-related events, including respiratory depression. For older adults, the sedation and confusion gabapentin causes can be more pronounced because aging kidneys clear the drug more slowly, leading to higher concentrations in the body at the same dose a younger person would tolerate easily.
The confusion and mental slowing that gabapentin can trigger in older adults sometimes gets mistaken for age-related cognitive decline or early dementia, when it may actually be a reversible drug side effect. This is especially common when gabapentin is combined with other sedating medications like opioids, muscle relaxants, or sleep aids. Several states have reclassified gabapentin as a Schedule V controlled substance due to rising misuse and overdose deaths, reflecting growing concern about its safety profile overall.
What Cognitive Side Effects Feel Like
People on gabapentin commonly describe their cognitive symptoms as “brain fog,” a catch-all term for a cluster of related problems. You might find it harder to recall words, lose your train of thought mid-sentence, struggle to concentrate on reading, or feel mentally “slow” in a way that’s hard to pin down. Some people notice they forget conversations or appointments more often. Others describe feeling detached or like they’re thinking through cotton wool.
These symptoms tend to be worst when you first start the medication or after a dose increase, and they often improve somewhat as your body adjusts over the first few weeks. But for some people, the cognitive dulling persists as long as they’re on the drug. The sedation that impairs driving ability is well documented, and it overlaps with the same brain-slowing effects that cause memory complaints.
Can Memory Recover After Stopping?
The short-term cognitive effects of gabapentin, like confusion, sedation, and difficulty concentrating, are generally considered reversible once the drug is discontinued or the dose is reduced. Because gabapentin has a relatively short half-life of five to seven hours, the acute brain fog typically clears within days to a couple of weeks after stopping.
However, gabapentin should never be stopped abruptly. Sudden discontinuation can trigger increased seizure activity, even in people who don’t have epilepsy. A gradual taper under medical supervision is the standard approach. Whether long-term use causes lasting cognitive changes that persist after stopping is less clear. The dementia risk findings from population studies raise this possibility, but no controlled studies have tracked cognitive recovery in detail over months or years after discontinuation. If you’re concerned about memory problems on gabapentin, a supervised dose reduction is the most practical first step to determine whether the drug is the cause.